Focus: Zynex Medical is a publicly traded medical device company founded in 1996, focused on neuromodulation and functional electrical stimulation therapies for neurological indications. The company operates as a specialized device manufacturer with a footprint in chronic pain and stroke rehabilitation.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
No open roles listed right now. Follow Zynex Medical to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Flagship program in core chronic pain market with 1 active trial, but limited clinical advancement data available.
Help build intelligence for Zynex Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Zynex Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
8-K Filing: ZYNEX INC (ZYXIQ) (CIK 0000846475) — EX-10.1
EX-10.1
Patient recounts fraud experience with Colorado medical company after former executives indicted - CBS News
Patient recounts fraud experience with Colorado medical company after former executives indicted CBS News
Former executives of device maker Zynex Medical indicted for fraud - statnews.com
Former executives of device maker Zynex Medical indicted for fraud statnews.com
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 8 publications